Biotricity Historical Balance Sheet

BTCY Stock

USD 1.24 0.14 12.73%

Trend analysis of Biotricity balance sheet accounts such as Short Long Term Debt Total of 23.6 M, Other Current Liabilities of 977.3 K or Total Current Liabilities of 13.5 M provides information on Biotricity's total assets, liabilities, and equity, which is the actual value of Biotricity to its prevalent stockholders. By breaking down trends over time using Biotricity balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Biotricity latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biotricity is a good buy for the upcoming year.

Biotricity Inventory

2.82 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

About Biotricity Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Biotricity at a specified time, usually calculated after every quarter, six months, or one year. Biotricity Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biotricity and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biotricity currently owns. An asset can also be divided into two categories, current and non-current.

Biotricity Balance Sheet Chart

Biotricity Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Biotricity uses and utilizes its capital. It also shows what exactly a company owns and owes.

At this time, Biotricity's Total Liabilities is fairly stable compared to the past year. Short Term Debt is likely to rise to about 6.2 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 977.3 K in 2024.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Common Stock Total Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Biotricity assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biotricity books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Biotricity balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biotricity are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Most accounts from Biotricity's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Biotricity current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.At this time, Biotricity's Total Liabilities is fairly stable compared to the past year. Short Term Debt is likely to rise to about 6.2 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 977.3 K in 2024.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	15.4M	19.5M	22.5M	23.6M
Total Assets	16.7M	6.5M	7.5M	7.9M

Short Long Term Debt Total Total Assets

Biotricity balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Short Term Investments	Inventory
Total Assets		0.78	0.2	0.6	-0.49	0.61	0.53	-0.81	0.57	0.82	0.82	0.89	0.58	0.28	0.8	0.79	0.76	0.97	0.57	0.7	-0.3	0.76	0.83	0.75	0.68	0.62
Short Long Term Debt Total	0.78		0.24	0.88	-0.9	0.72	0.94	-0.93	0.95	0.3	0.3	0.9	0.6	0.34	0.99	0.92	0.99	0.62	0.88	0.74	-0.26	0.99	0.87	0.78	0.97	0.97
Other Current Liab	0.2	0.24		0.63	-0.4	0.38	0.23	-0.4	0.31	0.06	0.06	0.44	0.53	0.1	0.17	0.38	0.35	0.2	0.56	0.46	-0.92	0.14	0.25	0.2	0.35	0.2
Total Current Liabilities	0.6	0.88	0.63		-0.93	0.77	0.88	-0.9	0.92	0.1	0.1	0.87	0.7	0.31	0.82	0.88	0.93	0.44	0.99	0.77	-0.62	0.83	0.74	0.69	0.94	0.87
Total Stockholder Equity	-0.49	-0.9	-0.4	-0.93		-0.67	-0.97	0.85	-0.97	0.07	0.07	-0.75	-0.58	-0.3	-0.86	-0.82	-0.93	-0.31	-0.94	-0.69	0.38	-0.89	-0.75	-0.68	-0.95	-0.95
Current Deferred Revenue	0.61	0.72	0.38	0.77	-0.67		0.65	-0.88	0.76	0.26	0.26	0.77	0.9	0.33	0.68	0.91	0.75	0.5	0.81	0.89	-0.49	0.69	0.62	0.7	0.75	0.67
Net Debt	0.53	0.94	0.23	0.88	-0.97	0.65		-0.83	0.98	-0.04	-0.04	0.75	0.49	0.3	0.92	0.82	0.95	0.33	0.9	0.63	-0.21	0.94	0.75	0.66	0.96	0.99
Retained Earnings	-0.81	-0.93	-0.4	-0.9	0.85	-0.88	-0.83		-0.89	-0.4	-0.4	-0.94	-0.82	-0.37	-0.9	-0.97	-0.94	-0.7	-0.9	-0.91	0.48	-0.9	-0.87	-0.86	-0.92	-0.86
Accounts Payable	0.57	0.95	0.31	0.92	-0.97	0.76	0.98	-0.89		0.02	0.02	0.79	0.63	0.32	0.92	0.89	0.96	0.38	0.94	0.74	-0.32	0.94	0.75	0.72	0.96	0.98
Cash	0.82	0.3	0.06	0.1	0.07	0.26	-0.04	-0.4	0.02		1.0	0.53	0.33	0.12	0.35	0.38	0.26	0.92	0.05	0.39	-0.18	0.27	0.48	0.43	0.15	0.07
Cash And Short Term Investments	0.82	0.3	0.06	0.1	0.07	0.26	-0.04	-0.4	0.02	1.0		0.53	0.33	0.12	0.35	0.38	0.26	0.92	0.05	0.39	-0.18	0.27	0.48	0.43	0.15	0.07
Net Receivables	0.89	0.9	0.44	0.87	-0.75	0.77	0.75	-0.94	0.79	0.53	0.53		0.7	0.33	0.86	0.9	0.91	0.8	0.85	0.8	-0.51	0.86	0.86	0.8	0.9	0.8
Common Stock Total Equity	0.58	0.6	0.53	0.7	-0.58	0.9	0.49	-0.82	0.63	0.33	0.33	0.7		0.49	0.58	0.82	0.64	0.55	0.71	0.97	-0.63	0.56	0.64	0.72	0.61	0.52
Common Stock Shares Outstanding	0.28	0.34	0.1	0.31	-0.3	0.33	0.3	-0.37	0.32	0.12	0.12	0.33	0.49		0.33	0.35	0.34	0.24	0.32	0.49	-0.09	0.33	0.35	0.33	0.34	0.32
Non Current Liabilities Total	0.8	0.99	0.17	0.82	-0.86	0.68	0.92	-0.9	0.92	0.35	0.35	0.86	0.58	0.33		0.9	0.97	0.65	0.82	0.73	-0.2	0.99	0.87	0.76	0.92	0.95
Other Stockholder Equity	0.79	0.92	0.38	0.88	-0.82	0.91	0.82	-0.97	0.89	0.38	0.38	0.9	0.82	0.35	0.9		0.93	0.66	0.89	0.9	-0.44	0.89	0.81	0.79	0.89	0.86
Total Liab	0.76	0.99	0.35	0.93	-0.93	0.75	0.95	-0.94	0.96	0.26	0.26	0.91	0.64	0.34	0.97	0.93		0.6	0.93	0.77	-0.37	0.97	0.86	0.78	0.98	0.97
Total Current Assets	0.97	0.62	0.2	0.44	-0.31	0.5	0.33	-0.7	0.38	0.92	0.92	0.8	0.55	0.24	0.65	0.66	0.6		0.41	0.66	-0.3	0.59	0.78	0.7	0.5	0.43
Short Term Debt	0.57	0.88	0.56	0.99	-0.94	0.81	0.9	-0.9	0.94	0.05	0.05	0.85	0.71	0.32	0.82	0.89	0.93	0.41		0.77	-0.57	0.85	0.72	0.72	0.95	0.89
Common Stock	0.7	0.74	0.46	0.77	-0.69	0.89	0.63	-0.91	0.74	0.39	0.39	0.8	0.97	0.49	0.73	0.9	0.77	0.66	0.77		-0.55	0.71	0.8	0.83	0.73	0.66
Net Tangible Assets	-0.3	-0.26	-0.92	-0.62	0.38	-0.49	-0.21	0.48	-0.32	-0.18	-0.18	-0.51	-0.63	-0.09	-0.2	-0.44	-0.37	-0.3	-0.57	-0.55		-0.18	-0.27	-0.36	-0.36	-0.19
Non Current Assets Total	0.76	0.99	0.14	0.83	-0.89	0.69	0.94	-0.9	0.94	0.27	0.27	0.86	0.56	0.33	0.99	0.89	0.97	0.59	0.85	0.71	-0.18		0.86	0.79	0.95	0.97
Non Currrent Assets Other	0.83	0.87	0.25	0.74	-0.75	0.62	0.75	-0.87	0.75	0.48	0.48	0.86	0.64	0.35	0.87	0.81	0.86	0.78	0.72	0.8	-0.27	0.86		0.86	0.82	0.8
Other Assets	0.75	0.78	0.2	0.69	-0.68	0.7	0.66	-0.86	0.72	0.43	0.43	0.8	0.72	0.33	0.76	0.79	0.78	0.7	0.72	0.83	-0.36	0.79	0.86		0.75	0.7
Short Term Investments	0.68	0.97	0.35	0.94	-0.95	0.75	0.96	-0.92	0.96	0.15	0.15	0.9	0.61	0.34	0.92	0.89	0.98	0.5	0.95	0.73	-0.36	0.95	0.82	0.75		0.97
Inventory	0.62	0.97	0.2	0.87	-0.95	0.67	0.99	-0.86	0.98	0.07	0.07	0.8	0.52	0.32	0.95	0.86	0.97	0.43	0.89	0.66	-0.19	0.97	0.8	0.7	0.97

Click cells to compare fundamentals

Biotricity Account Relationship Matchups

Biotricity balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.0M	4.4M	16.7M	6.5M	7.5M	7.9M
Short Long Term Debt Total	2.3M	4.7M	15.4M	19.5M	22.5M	23.6M
Other Current Liab	427.6K	3.6M	520.7K	1.0M	1.2M	977.3K
Total Current Liabilities	3.8M	10.5M	4.9M	11.2M	12.8M	13.5M
Total Stockholder Equity	(3.0M)	(6.8M)	(2.1M)	(19.8M)	(17.9M)	(17.0M)
Net Debt	1.4M	2.5M	3.3M	19.0M	21.8M	22.9M
Retained Earnings	(46.4M)	(62.8M)	(93.0M)	(112.6M)	(101.3M)	(96.2M)
Accounts Payable	1.1M	1.0M	1.2M	3.4M	4.0M	4.1M
Cash	949.8K	2.2M	12.1M	570.5K	656.0K	623.2K
Cash And Short Term Investments	949.8K	2.2M	12.1M	570.5K	656.0K	623.2K
Net Receivables	623.3K	1.8M	2.4M	1.8M	2.1M	2.2M
Common Stock Total Equity	31.9K	35.4K	36.4K	39.0K	44.9K	27.8K
Common Stock Shares Outstanding	6.0M	6.3M	7.6M	8.7M	10.0M	7.3M
Liabilities And Stockholders Equity	2.0M	4.4M	16.7M	6.5M	7.5M	7.9M
Non Current Liabilities Total	1.2M	780.9K	14.0M	15.2M	17.5M	18.3M
Other Stockholder Equity	44.2M	56.6M	91.6M	92.8M	106.7M	112.1M
Total Liab	5.0M	11.3M	18.8M	26.4M	30.3M	31.8M
Total Current Assets	1.7M	4.3M	15.3M	4.7M	5.4M	3.2M
Accumulated Other Comprehensive Income	(857.3K)	(634.2K)	(768.7K)	(152.8K)	(137.5K)	(144.4K)
Short Term Debt	2.3M	4.3M	1.8M	5.1M	5.9M	6.2M
Common Stock	36.4K	39.0K	51.3K	52.5K	60.4K	33.8K
Net Tangible Assets	(1.8M)	(3.0M)	(6.8M)	(2.1M)	(1.9M)	(2.0M)
Non Current Assets Total	345.6K	116.5K	1.4M	1.8M	2.1M	2.2M
Short Term Investments	137.1K	326.7K	302.3K	588.6K	676.9K	710.7K
Inventory	85.7K	272.5K	842.9K	2.3M	2.7M	2.8M
Other Current Assets	137.1K	326.7K	406.3K	588.6K	676.9K	710.7K
Short Long Term Debt	2.1M	4.3M	1.5M	4.8M	5.5M	5.8M
Net Invested Capital	(932.1K)	(2.2M)	11.9M	(2.0M)	(2.3M)	(2.2M)
Net Working Capital	(2.1M)	(6.2M)	10.5M	(6.4M)	(5.8M)	(5.5M)
Capital Stock	36.4K	39.0K	51.3K	52.5K	60.4K	47.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

WD	Walker Dunlop
MSFT	Microsoft
BAC	Bank of America

When determining whether Biotricity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biotricity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biotricity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biotricity Stock:

How To Invest In Biotricity

Details

Is Biotricity Stock a good investment?

Details

What is Biotricity's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Biotricity Stock analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.

	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Transaction History View history of all your transactions and understand their impact on performance
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges

Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.75)

Revenue Per Share

1.319

Quarterly Revenue Growth

0.209

Return On Assets

(0.95)

Return On Equity

(41.01)

The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biotricity Historical Balance Sheet

Biotricity Inventory

2.82 Million

About Biotricity Balance Sheet Analysis

Biotricity Balance Sheet Chart

Total Assets

Total Current Liabilities

Common Stock Total Equity

Biotricity balance sheet Correlations

Biotricity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biotricity balance sheet Accounts

Also Currently Popular

Complementary Tools for Biotricity Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.99	Short Long Term Debt Total
Short Term Debt	+ 0.99	Total Current Liabilities
Inventory	+ 0.99	Net Debt

Other Stockholder Equity	- 0.97	Retained Earnings
Accounts Payable	- 0.97	Total Stockholder Equity
Net Debt	- 0.97	Total Stockholder Equity
Inventory	- 0.95	Total Stockholder Equity
Short Term Investments	- 0.95	Total Stockholder Equity
Total Liab	- 0.94	Retained Earnings